Parnell Pharmaceuticals Holdings Ltd
PARN
PARN was delisted on the 30th of December, 2016.
18 hedge funds and large institutions have $16.1M invested in Parnell Pharmaceuticals Holdings Ltd in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
20% more funds holding
Funds holding: 15 → 18 (+3)
27% less capital invested
Capital invested by funds: $22.1M → $16.1M (-$5.92M)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$324K |
| 2 |
Goldman Sachs
New York
|
+$209K |
| 3 |
PA
Perceptive Advisors
New York
|
+$18.6K |
| 4 |
Morgan Stanley
New York
|
+$100 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$646K |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$424K |
| 3 |
D.E. Shaw & Co
New York
|
-$163K |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$79.3K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$78.1K |
PARN Hedge Fund Activity: Q4 2014 in Review
18 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q4 2014, worth a combined $16.1M — down 27% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PARN positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 8 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $324K. The largest seller was Pacific Alternative Asset Management Company (PAAMCO), exiting entirely with an estimated $646K sold.
- 18 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q4 2014, up from 15 in Q3 2014.
- Funds reported $16.1M of Parnell Pharmaceuticals Holdings Ltd stock for Q4 2014, down 27% quarter-over-quarter.
- 6 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q4 2014 and 2 closed out, a net change of +4 holders.
- The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q4 2014 was JP Morgan Chase, an estimated $324K added.
- The largest Parnell Pharmaceuticals Holdings Ltd seller in Q4 2014 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $646K sold.
Based on aggregated 13F filings for Q4 2014.